GPC
45
5
GT
65
3
BDX
46
-6
TRV
58
2
EXR
64
4
SO
59
6
KLAC
56
9
F
60
2
TROW
61
5
MSI
70
-3
EOG
51
-7
EL
31
6
PEP
50
2
VFC
57
4
HSY
38
3
CRM
65
-2
CA
47
9
KO
49
5
HBI
55
-4
M
33
-4
GPC
45
5
GT
65
3
BDX
46
-6
TRV
58
2
EXR
64
4
SO
59
6
KLAC
56
9
F
60
2
TROW
61
5
MSI
70
-3
EOG
51
-7
EL
31
6
PEP
50
2
VFC
57
4
HSY
38
3
CRM
65
-2
CA
47
9
KO
49
5
HBI
55
-4
M
33
-4
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
57.90
Seasonality Move:
16.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 24.4% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $58.30. The Score for BIB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 24.4% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
43
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
42.84

Prediction Charts

Market Cap:
0
Price in USD:
58.30
Volume:
15.57K
Beta:
1.84

Technical Analysis

SMA50:
62.23
SMA100:
63.62
SMA200:
59.93
52-Wk Change:
32.26%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 58.30 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-6 65.00 64.31 65.00 63.50
Nov-7 64.72 65.98 66.17 64.72
Nov-8 65.20 66.86 67.00 65.20
Nov-11 67.18 66.34 68.00 66.20
Nov-12 65.15 62.76 65.76 62.69
Nov-13 62.84 61.75 64.04 61.73
Nov-14 60.97 58.97 61.15 58.68
Nov-15 58.00 53.66 58.00 53.50
Nov-18 53.66 53.40 53.67 52.79
Nov-19 52.52 53.52 53.71 52.19
Nov-20 53.80 54.31 54.44 53.33
Nov-21 54.39 55.10 55.44 53.42
Nov-22 55.19 56.84 57.24 55.19
Nov-25 57.90 58.30 59.13 57.90

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.